The Capital Commitment

Proskauer on Private Fund Litigation

Photo of David W. Heck

David W. Heck

Associate

David Heck is a commercial litigator with an emphasis on intellectual property and antitrust matters. He has experience across all phases of the legal process, from advisory matters to trial, and has represented clients from various industries, including consumer product manufacturers, private equity firms, medical supply companies, and sports and entertainment entities. In particular, David has handled false advertising cases for both plaintiffs and defendants; trademark infringement claims; antitrust prosecutions and class actions; breach of contract claims; employment disputes; and securities litigations and investigations.

David also maintains an active pro bono practice and has been awarded Proskauer’s Golden Gavel award for excellence in pro bono work. He frequently represents military veterans in matters with the Department of Veterans Affairs and has served clients in a broad range of immigration matters.

Prior to law school, David worked as an editorial producer for MLB Advanced Media.

Subscribe to all posts by David W. Heck

An Overview of OFAC’s Ongoing Guidance: Chinese Military Companies Trading Ban

Over the past few weeks, the U.S. Treasury Department’s Office of Foreign Assets Control (OFAC) has issued further guidance in the form of Frequently Asked Questions (FAQs) and General Licenses that clarify the terms of the Order and its Chinese Military Sanctions Program. To a large degree, OFAC’s guidance confirms that the agency will interpret … Continue Reading

Crypto Asset Regulation: Is the US or UK Keeping Up Best With This Emerging Market?

One driver for the first widely adopted cryptocurrency Bitcoin was to create a store of value that existed outside of government control. It is therefore no surprise that attempts to regulate the rapidly developing crypto asset market have required great efforts from regulators and legislators around the world to keep apace. In this blog, we … Continue Reading

Poison Pills In the Wake of COVID-19: A Refresher on Terms and Variations of Shareholder Rights Plans

Shareholder rights plans, commonly known as “poison pills,” are arrangements that can be used by companies to stave off hostile takeovers or activist investors seeking to exert control over a company without paying a control premium. A typical rights plan, if triggered, would allow all shareholders except the triggering person to purchase additional shares in … Continue Reading

Top Ten Regulatory and Litigation Risks for Private Funds in 2020

The private fund industry is more in the public eye than ever before.  Private capital and private markets have experienced massive growth over the last two decades, substantially outpacing the growth of public equity. We have witnessed that trend continue during the past year, and have worked with our clients to navigate the greater uncertainty … Continue Reading
LexBlog